Current Roles

Employees:
37
Revenue:
$7.5M
About
BrainStorm (OTC.BB: BCLI) is an emerging company developing stem cell therapeutic products based on breakthrough technologies. BrainStorm\'s core technology, NurOwn™, was developed through a collaboration between prominent neurologist, Prof. Eldad Melamed, Head of Neurology of the Rabin Medical Center and member of the Scientific Committee of Michael J. Fox Foundation for Parkinson\'s Research and expert cell biologist Dr. Daniel Offen, at the Felsenstein Medical Research Center of Tel-Aviv University.
Brainstorm Cell Therapeutics Address
1325 Avenue of Americas
New York, NY
United States
Brainstorm Cell Therapeutics Email
Brainstorm Cell Therapeutics Phone Numbers
+12014880460

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.